42Z

REVOLUTION MED. DL-0001

Healthcare · EUR · F

42Z

Price

€134.81

+3.89%

Cap

€30.15B

Earnings

30d Trend

+10.3%

42Z
Loading chart data...
0 days · % change from startPowered by Brain47
52-week range100%
€29.63€134.81

Near 52-week highs — limited upside before resistance

VolatilityHigh

73% annualised over 90 days

BRAIN47 SIGNAL

0
MODERATE
Risk Level69
Quality38
Momentum80
Technical54
Fundamentals26

Raw weighted: 52×Macro 0.99 (1%)=50

RISK LEVEL

69/100
90d Volatility
72.8%High
ATR %
4.2%High daily moves
Max Drawdown (1Y)
-25.0%Normal

QUALITY

38/100
ROE (avg)
-76.7%*Negative
Piotroski F-Score
3/9Weak
Debt/Equity
0.10Low leverage
Accruals
-9.9%Cash earnings

MOMENTUM

80/100
6-1M Momentum
+92.8%Positive
1M Return
+5.6%Strong recent gains

TECHNICAL

54/100
RSI (14)
55.5Neutral
Price vs SMA200
+65.9%Bullish trend
MACD
-1.40Bearish momentum
Bollinger Band
62%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.060Noisy/choppy

FUNDAMENTALS

26/100
P/S
9035.1Expensive
Shareholder Yield
0.0%Low

Macro: neutral (×0.99) - Fear/Greed: 61 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months50
3-12 months83
1-5+ years38

6-9 month momentum thesis — strong trend with confirmation

BRAIN47'S ASSESSMENT

I rate REVOLUTION MED. DL-0001 at 50/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is momentum at 80/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

PAST PERFORMANCE

1 MONTH

+5.6%

3 MONTHS

+55.4%

12 MONTHS

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

6-9 month momentum thesis — strong trend with confirmation. Momentum (80) and Technical (54) are the primary strengths. I note that fundamentals is the weakest area at 26/100 — this warrants monitoring. Historical volatility is elevated at 73%. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.

growthScore: 50/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.